arrow
Return

“Pharmacological risk stratification of Lp(a): diabetes status may refine residual cardiovascular risk beyond ASCVD history” - authors’ reply

delete2026-07-30
delete0
PRE
AI
S
Sam-Lennart Oftadeh
D
Dirk Müller‐Wieland
M
Marlo Verket *
DOI:10.1093/eurjpc/zwag403delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En

Journal

European Journal of Preventive Cardiology cover
European Journal of Preventive Cardiology
IF:
7.5
Papers:
5.8K
Citations:
1.2W

Organization

U
University Hospital RWTH Aachen
Scholars:
283
Papers: 83
Citations: 1